Quantinuum (NASDAQ:QNT – Get Free Report) was upgraded by stock analysts at Wall Street Zen from a “sell” rating to a “hold” rating in a note issued to investors on Saturday, Wall Street Zen reports.
Several other research firms have also recently weighed in on QNT. Weiss Ratings assumed coverage on Quantinuum in a research note on Monday, August 31st. They set a “sell (d)” rating for the company. Yorkville Ives started coverage on Quantinuum in a report on Monday, October 5th. They set an “outperform” rating and a $60.00 price target on the stock. Rosenblatt Securities reaffirmed a “buy” rating and issued a $155.00 price objective on shares of Quantinuum in a research report on Thursday, October 22nd. Jefferies Financial Group dropped their price target on shares of Quantinuum from $85.00 to $65.00 and set a “buy” rating on the stock in a research note on Friday. Finally, Needham & Company LLC reduced their target price on shares of Quantinuum from $100.00 to $60.00 and set a “buy” rating for the company in a report on Friday. Thirteen analysts have rated the stock with a Buy rating, two have assigned a Hold rating and one has given a Sell rating to the company’s stock. Based on data from MarketBeat.com, Quantinuum presently has a consensus rating of “Moderate Buy” and an average target price of $85.62.
Check Out Our Latest Stock Report on Quantinuum
Quantinuum Price Performance
Shares of NASDAQ QNT opened at $37.57 on Friday. The company has a fifty day moving average of $43.41. Quantinuum has a fifty-two week low of $28.31 and a fifty-two week high of $86.79.
Quantinuum (NASDAQ:QNT – Get Free Report) last issued its quarterly earnings results on Thursday, November 5th. The company reported ($0.29) EPS for the quarter, beating the consensus estimate of ($0.99) by $0.70. The firm had revenue of $9.05 million for the quarter. As a group, equities research analysts predict that Quantinuum will post -4.76 earnings per share for the current year.
Institutional Investors Weigh In On Quantinuum
Institutional investors and hedge funds have recently added to or reduced their stakes in the business. Wellington Management Group LLP purchased a new stake in Quantinuum in the 2nd quarter worth approximately $92,418,000. HBK Investments L P purchased a new stake in shares of Quantinuum during the second quarter worth $14,669,000. BlueCrest Capital Management Ltd acquired a new stake in shares of Quantinuum in the 2nd quarter valued at approximately $14,304,000. Readystate Asset Management LP purchased a new stake in Quantinuum in the second quarter valued at approximately $4,111,000. Finally, Light Street Capital Management LLC acquired a new position in Quantinuum in the second quarter worth about $2,881,000.
Key Quantinuum News
Here are the key news stories impacting Quantinuum this week:
- Positive Sentiment: Quantinuum beat third-quarter expectations, reporting a loss of $0.29 per share versus the $0.99 loss analysts expected. Revenue rose 233% year over year to $9.05 million, and the company raised its full-year 2026 revenue outlook. The report also noted that gross margin turned positive, although expenses are increasing. Quantinuum Q3 results and outlook
- Positive Sentiment: Commercial traction strengthened: Quantinuum said it secured its largest cloud agreement to date, expanded access through a hyperscaler and an Oracle beta launch, and saw platform adoption rise nearly 20% quarter over quarter. These developments could help build future revenue. Quantinuum Q3 results and outlook
- Positive Sentiment: The company outlined its Nexus developer-platform roadmap, connecting application development with future hardware, including its planned Apollo fault-tolerant quantum computer. The roadmap and reported technical milestones could strengthen Quantinuum’s longer-term competitive position. Nexus roadmap announcement
- Negative Sentiment: Some analysts lowered their forecasts and price targets after the results. Cantor Fitzgerald cut its target from $90 to $55 and Needham lowered its target from $100 to $60, though both retained positive ratings—Overweight and Buy, respectively. The cuts may temper enthusiasm despite the earnings beat. Analysts cut forecasts after Q3 results
About Quantinuum
Quantinuum is a quantum computing company formed in 2021 through the combination of Honeywell Quantum Solutions and Cambridge Quantum. The company develops full-stack quantum computing technologies designed to support research and commercial applications across industries, including chemistry, materials science, cybersecurity, finance and artificial intelligence.
Its offerings include trapped-ion quantum computers, quantum software and development tools. Quantinuum’s software portfolio includes the TKET quantum compiler, InQuanto quantum chemistry platform, Quantum Origin quantum-enhanced cybersecurity solutions and the Nexus platform for developing and managing quantum applications.
Featured Stories
- Five stocks we like better than Quantinuum
- Q3 Earnings Have Investors Wondering: Is Mercado Libre Finally a Buy?
- CVS Raised Its Outlook and Announced a Breakup—So Why Did the Stock Drop?
- Array and Shoals Are Merging: Who Really Wins the All-Stock Solar Deal?
- Duolingo’s User Growth Is Outpacing Bookings, But Is Its Strategy Paying Off?
Receive News & Ratings for Quantinuum Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Quantinuum and related companies with MarketBeat.com's FREE daily email newsletter.
